MedPath

Comparison of effectiveness of corticosteroid with dextrose in treatment of carpal tunnel syndrome.

Phase 2
Conditions
Carpal tunnel syndrome.
Carpal tunnel syndrome
G56.0
Registration Number
IRCT20180603039969N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
54
Inclusion Criteria

Patients with clinical diagnosis of carpal tunnel syndrome (paresthesia over the median nerve territory in the hand).
Mild to moderate severity of carpal tunnel syndrome, based on electrodiagnostic studies.
Age between 18-65 years,

Exclusion Criteria

Severe CTS ( based on electrodiagnostic data).
Signs of thenar atrophy.
Contraindication for injection ( such as history of hypersensitivity to corticosteroid, signs of local infection, immune deficiency, needle phobia.
Diseases that mimic symptoms of carpal tunnel syndrome such as polyneuropathy, radiculopathy, and thoracic outlet syndrome.
Surgical treatment or local injection in the last six months.
Neoplastic or traumatic origin.
Tenderness and fracture of wrist bones.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain intensity (Visual analogue scale). Timepoint: Baseline, and after 2 weeks, one month and 6 months after injection. Method of measurement: 10 point VAS scale.;Electrodiagnosis parameters. Timepoint: Baseline, and after 2 weeks, one month and 6 months after injection. Method of measurement: Electrodiagnostic study machine.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath